News + Filings Holdings
All 13F 13D/G Other
|
Crestline Management, LP
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/17/2021 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 2,216,798 shares
@ $65, valued at
$144.1M
|
|
02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2020 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 1,443,247 shares
@ $31.65, valued at
$45.7M
|
|
08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2020 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 1,922,855 shares
@ $25.75, valued at
$49.5M
|
|
05/13/2020 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
05/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/04/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/28/2020 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Sold 3,894,764 shares
@ $20.25, valued at
$78.9M
|
|
02/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
12/14/2017 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.
Txns:
| Converted 14,499,999 shares
@ $0 Converted 2,500,000 shares
@ $0 Converted 1,875,000 shares
@ $0 Converted 743,599 shares
@ $0 Converted 128,200 shares
@ $0 Converted 240,000 shares
@ $0 Bought 275,000 shares
@ $18, valued at
$5M
Converted 14,499,999 convertible preferred
@ $0 Converted 2,500,000 convertible preferred
@ $0 Converted 1,875,000 convertible preferred
@ $0 Converted 743,599 convertible preferred
@ $0 |
|
12/07/2017 |
3
| BRATTON DOUGLAS K (10% Owner) has filed a Form 3 on Denali Therapeutics Inc. |
11/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/14/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|